Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease

Figure 1

Identification of the exosomes isolated from the serum of the control subjects and the SCAD patients. (a) Transmission electron microscopy showing the morphology of exosomes. (b) Nanoparticle tracking analysis showing the concentration and size of the isolated vehicles. (c) Western blot analysis showing the expression of positive and negative markers including CD63, Tsg101, Flotillin, and Calnexin in the isolated vehicles. SCAD: stable coronary artery disease.

(a)

(b)

(c)